The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1025-1031

  Mrowietz, U ^a   Schwenk, U ^a   Maune, S ^a   Bartels, J ^a   Kupper M ^a   Fichtner, I ^b   Schroder J M ^a   Schadendorf, D ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chemokine; Human; Melanoma; Metastasis; RANTES

Indexed keywords

CHEMOKINE; RANTES;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CHEMOTAXIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MELANOMA CELL; MONOCYTE; MOUSE; NONHUMAN; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BLOTTING, WESTERN; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-8; MALE; MELANOMA; MICE; MICE, NUDE; RANTES; TUMOR CELLS, CULTURED;

EID: 0033021558     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690164     Document Type: Article

References (31)

1. Artuc M, Nürnberg W, Czarnetzki BM and Schadendorf D (1995) Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun 213: 699-705
2. Balaban G, Herlyn M, Guerry D4, Bartolo R, et al (1984) Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11: 429-439
3. Barnhill RL (1993) Pathology and prognostic factors. Curr Opin Oncol 5: 364-376
4. Benomar A, Ming WJ, Taraboletti G, Ghezzi P, et al (1987) Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. J Immunol 138: 2372-2379
5. Bottazzi B, Polentarutti N, Acero R, Balsari A, et al (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210-212
6. Bröcker EB, Zwadlo G, Holzmann B, Macher E, et al (1988) Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer 41: 562-567
7. Cornil I, Theodorescu D, Man S, Herlyn M, et al (1991) Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 88: 6028-6032
8. Degli-Esposti MA, Davis-Smith T, Din WS, Smolak PJ, et al (1997) Activation of the lymphotoxin β receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. J Immunol 158: 1756-1762
9. 32P-based hybridizations. Anal Biochem 210: 235-239.
10. Ferrone S (1994) Melanoma, immune surveillance, and immunotherapy. J Clin Invest 93: 1351-1352
11. Gläser R, Rass K, Seiter S, Hauschild A, et al (1997) Detection of circulating melanoma cells by specific amplification of tyrosinase complentary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 15: 2818-2825
12. Graves DT, Barnhill R, Galanopoulos T and Antoniades HN (1992) Expression of monocyle chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140: 9-14
13. Herlyn M, Balaban G, Bennicelli J, Guerry D4, et al (1985a) Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Invest 74: 283-289
14. Herlyn M, Thurin J, Balaban G, Bennicelli JL, et al (1985b) Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45: 5670-5676
15. Ibrahim MA, Chain BM and Katz DR (1995) The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 16: 181-186.
16. Mattei S, Colombo MP, Melani C, Silvani A, et al (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853-857
17. Mrowietz U and Jürgens G (1995) A method for the determination of leukocyte migration for large sample numbers by automated densitometric quantification. J Biochem Biophys Methods 30: 49-58
18. Rigel DS, Friedman RJ and Kopf AW (1996) The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 34: 839-847
19. Rivers JK (1996) Melanoma. Lancet 347: 803-806
20. Schadendorf D, Möller A, Algermissen B, Worm M, et al (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151: 2667-2675
21. Schadendorf D, Fichtner I, Makki A, Alijagic S, et al (1996) Metastatic potential of human melanoma cells in nude mice - characterization of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 74: 194-199.
22. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, et al (1988) A human T cell-specific molecule is a member of a new gene family. J Immunol 141: 1018-1025.
23. Schall TJ, Bacon K, Toy KJ and Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
24. Schall TJ and Bacon KB (1994) Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6: 865-873
25. Singh RK and Varney ML (1998) Regulation of interleukin 8 expression in human malignant melanoma cells. Cancer Res 58: 1532-1537
26. Sozzani S, Sallusto F, Luini W, Zhou D, et al (1995) Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 155: 3292-3295
27. Sticherling M, Schröder JM and Christophers E (1989) Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. J Immunol 143: 1628-1634
28. Sticherling M, Küpper M, Koltrowitz F, Bornscheuer E, et al (1995) Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 105: 585-591
29. Te Velde AA and Figdor CG (1991) Monocyte-mediated cytotoxic activity against melanoma. Melanoma Res 1: 303-309
30. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, et al (1995) Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol 25: 64-68
31. + macrophages in antitumor cytotoxicity. Lab Invest 67: 166-174